• 18:32

    IMF: Economic recovery for developing countries will take years

    According to the International Monetary Fund (IMF), the economic recovery for developing and emerging countries is likely to take years. They lack access to vaccines and the financial headroom to support the economy. “The outlook for the poorer developing countries has darkened significantly,” said IMF chief economist Gita Gopinath.

    In contrast, industrialized countries, in which an average of around 60 percent of the population is vaccinated, can look forward to strong growth. On Tuesday, the IMF lowered its forecast for global economic growth this year by a marginal 0.1 percentage points to 5.9 percent. As in the previous forecast from July, the IMF continues to expect growth of 4.9 percent for 2022. The IMF emphasized that the new economic forecast was associated with great uncertainty.

  • 17:34

    Switzerland delivers thousands of Astrazeneca vaccination doses abroad

    Switzerland gives almost 440,000 vaccine doses against Covid-19 to five developing countries. The vaccine from the manufacturer Astrazeneca cannot be used in Switzerland because it is not approved.

    The first delivery of vaccines from Switzerland arrived in Sierra Leone, West Africa, on Saturday, as the international vaccination alliance Gavi announced in Geneva on Monday. According to Unicef, 165,600 vaccine doses are to be delivered to Pakistan in the next few weeks, 120,000 to Syria and 105,600 to Nigeria. Egypt, like Sierra Leone, receives 24,000 cans.

    At the end of June, the Federal Council decided to give 4 million doses of the Astrazeneca vaccine to the Covax vaccination program. Switzerland also supports the global vaccination campaign financially. In 2020, the Federal Council had spoken 20 million francs for this, and this year another 125 million francs were added.

  • 17:00

    New neutralizing antibody against coronavirus discovered

    A team from the ETH Lausanne (EPFL) and the University Hospital Lausanne (Chuv) discovered an antibody in blood samples from hospitalized Covid patients that effectively neutralizes all currently known coronavirus variants.

    Research shows that the antibody could prove to be a prophylactic agent in immunocompromised individuals who have poor response to vaccination. This is what the researchers report in the specialist magazine “Cell Reports”. In addition, as part of a combination therapy, the active ingredient could protect infected patients from a serious course of the disease.

    Talks with a start-up company for the clinical development of the antibody are currently being held. Clinical studies are planned for the end of 2022, the message said, Link opens in a new window.

  • 16:11

    Curevac withdraws vaccine candidates from approval processes

    The biotech company Curevac is withdrawing its first vaccine candidate from the approval process at the European Medicines Agency (EMA). As the company in Tübingen, Germany announced, it was assumed that EMA approval would not have been granted until the second quarter of 2022 at the earliest. There was no formal application for approval for the product.

    In late June, Curevac announced that its first-generation vaccine candidate was less effective than some other vaccines. The company still assumed that the EMA would approve the vaccine. The company wants to focus on the development of another Covid-19 vaccine with its British partner GlaxoSmithKline (GSK).


    Switzerland has secured 5 million vaccine doses from Curevac. She’s waiting for that until today.


  • 15:27

    Almost 1,800 vaccinations were administered in the Basel vaccination bus

    A total of 1,796 people in the Basel double-decker bus have been vaccinated against Covid-19 in the past four weeks. The Basel health department announced this on Tuesday in its Corona Bulletin. The vaccination bus was last used last Saturday after a four-week tour.

    The Basel vaccination bus mainly attracted young adults up to the age of 40. According to the notification, they had been vaccinated mainly because of the Covid certificate. For the over 40-year-olds, vaccination protection was mostly the motivation. The authorities are satisfied with the number of vaccinations given.

    According to the communiqué, there were no delicate situations with vaccination critics, although there was a meeting with a larger group of them. The vaccination bus is now paused. The authorities are considering using the bus again as part of the vaccination offensive announced by the federal government.

  • 14:41

    Ende des Point de Presse

    With this last question we conclude the reporting on the Point de Presse of the Federal Office of Public Health at specialist level. The next media information will take place on Tuesday, October 19 at 2 p.m.

    Thank you for your interest – we will keep you up to date on the current corona situation on the SRF news app or here in the live ticker.

  • 14:38

    Why isn’t Johnson & Johnson’s vaccine more popular?

    Linda Nartey cannot currently explain why the demand for the vector vaccine is not greater. Efforts to provide information and advice are still high, and there are also many vaccination offers. One hypothesis, however, is the following: People who have stated that they want to wait for the Johnson & Johnson vaccine may be more skeptical than assumed.

  • 14:37

    How many test centers are closing due to the quality requirements?

    The Bern canton doctor Linda Nartey says that she can only speak for the canton of Bern. One is in the process of finding a new order for the test centers. The test providers would have to contact us now and can only then be checked. You have no knowledge that test centers have closed due to the new requirements in the canton of Bern.

  • 14:35

    What about the infection rate in western Switzerland?

    Patrick Mathys (BAG) says that there is currently the highest virus circulation in central and eastern Switzerland. The trend shows that there is a tendency for new infections to cap off in western, southern and northwestern Switzerland.

  • 14:33

    Are online tests forbidden?

    Patrick Mathys answers shortly whether this type of test is permissible is currently being examined.

  • 14:31

    Shouldn’t the requirements for the test centers be the same across Switzerland?

    A journalist asks about the quality of the commercial test offers and wants to know whether Switzerland-wide guidelines are not needed.

    Patrick Mathys (BAG) says it makes sense that the cantons have a certain amount of leeway when it comes to the test strategy. The nasopharynx swab is preferable to a rapid nasal test. «If an adjustment is necessary here, we will do it. At the moment, however, both strategies can achieve good results with regard to a certificate. “

  • 14:30

    Increase minimum requirements for test centers?

    Should the minimum requirements for test centers be increased in order to guarantee quality, asks a journalist.

    The requirements are regulated in the ordinances, says Patrick Mathys (BAG). Therefore the requirements are given. The Bernese canton doctor Linda Nartey adds that the requirements are now being further formulated so that they are clearer for operators of test centers.

    It makes sense that the cantons have certain leeway, said Patrick Mathys. The operators of test centers should understand, however, that specialist staff are required, such as laboratory managers, pharmacists or doctors who monitor the tests.

  • 14:22

    When will the third vaccination come?

    A journalist says the European Medicines Agency (EMA) has approved the third vaccination and wants to know whether this will soon also be the case in Switzerland.

    Patrick Mathys (BAG) says Switzerland is currently examining the booster vaccination. But no decision has yet been made. When asked, Mathys specifies that on the one hand the vaccines must be approved for the booster vaccination. On the other hand, the application in and of itself must also be approved.

  • 14:22

    Q&A: Is the vaccination weakening?

    The question and answer session has started: a journalist wants to know whether the vaccine is wearing off.

    It is difficult to say how much the vaccine will wear off, says Patrick Mathys. The effectiveness is very high, but it does not work for everyone. It is therefore always to be expected that those who have been vaccinated will also become seriously ill and have to be hospitalized.

  • 14:18

    Nartey: “Demand for Janssen vaccine is modest”

    “The cantonal vaccination offers are constantly being adjusted,” says Linda Nartey, a canton doctor in Bern. The Janssen vaccine from Johnson & Johnson is now also being offered in all institutions. But the demand is modest.

  • 14:17

    Quality of commercial test offers

    Linda Nartey turns to the commercial test offers. For some providers, checks by the authorities as well as feedback from the population indicated quality deficiencies. Nartey refers to the importance of quality assurance, protection concepts or specialists in these offers. It is in the interests of everyone if the quality of these test offers meets the requirements, said the Vice President of the Association of Cantonal Doctors VKS.

  • 14:13

    Infection is likely to pick up speed again in the young population

    The infection seems to be capping itself, says Patrick Mathys. The decrease in new infections has decreased. In individual cantons there are already increasing numbers of corona cases. It can be assumed that the infection process in the young population will pick up speed again – especially after the autumn vacation. The virus is currently circulating most strongly in the age group of 10 to 19 year olds.

  • 14:10

    Intensive care units continue to be stressed

    The load on the intensive care units remains high, says Patrick Mathys about the numbers of hospitalizations and hospital admissions. Rapid relief for the seriously ill is not in prospect. The median age of corona patients in the intensive care unit is currently 57 years.

    Most of the patients in the hospitals are not vaccinated. Mathys emphasizes the benefit of the vaccination and says that it reliably protects against hospitalization. 69 percent of the population aged 12 and over who can be vaccinated is now fully vaccinated. There are currently around 30,000 vaccinations per day.

  • 14:04

    “Situation relatively good”

    Patrick Mathys opens the Point de Presse. “We can say that the situation is relatively good,” he says at the beginning. In some cantons, however, the number of cases would rise again. In addition, the new infections would stabilize. According to Mathys, this can also be determined when analyzing the wastewater for the corona virus.

  • 13:49

    Today 2 p.m. live: Point de Presse of the BAG

    Experts will provide information on the situation today at 2 p.m. Participants at the Point de Presse:

    • Patrick mathys, Head of the Crisis Management and International Cooperation Section, Federal Office of Public Health (FOPH)
    • Linda Nartey, Cantonal Doctor Bern, Vice President of the Association of Cantonal Doctors (VKS)

    We are broadcasting the media conference here in a live stream and on SRF info.

  • Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.